At the end of June, 2005, 5438+0 1, Lepu Company officially obtained the product registration certificate of "Rapamycin Drug-eluting Coronary Stent Delivery System" issued by the State Administration of Pharmaceutical Products. Since it was officially listed for nearly five months, it has produced more than 0/0000 drug stents/KLOC-0, with a sales income of more than 50 million yuan. Only in February 2005, the tax was paid 1.2 million yuan, which had economic benefits.
After seven years of tempering, at present, Lepu Company has 22 national patents, 1 1 three kinds of medical devices and two kinds of first-class products issued by the US Food and Drug Administration, and has the industrial production capacity of cardiovascular intervention, anesthesia monitoring and nursing. Products include coronary stent, PTCA balloon catheter, arterial sheath catheter, ultra-smooth guide wire, central venous catheter (CVC, PICC), pressure sensor, infusion pump and blood gas sampling box. Recently, partner drug-eluting coronary stents have been successfully listed, and the product sales network covers all provinces and cities in China except Tibet.
"Where is the future direction of the company? I believe that every Lepu employee will have a clear direction in his heart. " Talking about the prospect of the enterprise, Mr. Pu thinks that Lepu will form a good situation of product serialization, brand internationalization, talent echelon and sales networking under the premise of double guarantee of technology and quality, utilize the government resources and the existing technology, talents and market resources of the enterprise, integrate the existing medical device resources in Beijing, break the foreign monopoly, effectively limit the price of foreign products, and make more patients in China really widely use interventional medical products to build a domestic first-class national brand of medical devices. The development of all products is to serve people better, people-oriented and respect people's personality, which is very important. At present, when researching and developing many high-tech products in the west, we should consider how to better meet the characteristics and needs of human nature and whether the production process will cause damage to the human ecological environment. This idea is worth learning from China researchers.
Pu Zhongjie, the head of Lepu, based on honesty, high quality and scientific and technological innovation, revealed a deep humanistic knot at the beginning of the interview, which was unexpected, but at the same time deepened the reporter's interest in Pu Zhongjie and his medical career. (He Xun Finance was established in 1999, which was jointly funded by the 725th Research Institute of China Shipbuilding Industry Corporation and WP Company of the United States. As the founder of the company, Pu Zhongjie has always attached the company to the name of China Shipping. Lepu (Beijing) Medical Equipment Co., Ltd. was established in 1999, which was jointly funded by the 725th Research Institute of China Shipbuilding Industry Corporation and WP Company of the United States. The company is mainly engaged in the research, development, production and sales of coronary intervention medical devices, and it is one of the few enterprises in the field of high-end medical devices in China that can form strong competition with foreign products. Since its establishment, the company has successively completed the research and development and industrialization of a number of interventional medical core products such as stents and catheters. It is the first in the industry to obtain the product registration certificate of "coronary stent delivery system" (Class III) issued by the State Medical Products Administration, and the first to successfully develop and trial-produce the anti-infection "drug central venous catheter". The main products of Lepu (Beijing) Medical Devices Co., Ltd. include intravascular drug (rapamycin) eluting stent system, coronary stent delivery system, PTCA balloon dilatation catheter, drug central venous catheter and so on. The main products of Tiandi Sheikh, a holding subsidiary of the company, are anesthesia interventional medical supplies, sheaths and guide wires for cardiac interventional surgery. The main products of Shanghai Shapu, a holding subsidiary, are patent ductus arteriosus (PDA) occluder, atrial septal defect (ASD) occluder and ventricular septal defect (VSD) occluder. Lepu (Beijing) Medical Devices Co., Ltd. has nine third-class medical device product registration certificates issued by the State Medical Product Supervision Administration, 1 second-class medical device product registration certificates issued by the US Food and Drug Administration in Beijing, two first-class medical device product registration certificates issued by the US Food and Drug Administration in Beijing, and two product registration certificates are being applied for approval. It is an early enterprise in China that owns the coating technology of rapamycin drug stent, and it is also one of the few enterprises in China that owns independent technology to produce and process balloon dilatation catheter and contrast catheter. Around the drug stent and its supporting products, the company has 36 patents approved by the state and is applying for 30 patents (including 4 international patents).
Shanghai Shape and Shanghai Jixing, the holding subsidiaries of the Company, are mainly engaged in the research, development, production and sales of medical devices for cardiac interventional occluders. They are one of the major manufacturers of cardiac occluder products in China, and have five Class III medical device product registration certificates issued by the State Medical Products Administration, and obtained eight national patents.
Tiandi Sheikh is a holding subsidiary of Lepu (Beijing) Medical Devices Co., Ltd., which is mainly engaged in the research, development, production and operation of interventional anesthesia monitoring, interventional accessories and other medical devices. It has seven Class III medical device product registration certificates issued by the State Pharmaceutical Products Supervision Administration, 1 Class I medical device product registration certificates issued by the US Food and Drug Administration in Beijing, four Class II medical device product registration certificates and four national patents are under examination and approval.
According to the national and medical industry standards GB/T 1900 1 YY/T0287, the company established a strict medical device quality management system, and passed the certification in 2004. In 2007, the company became the first stent system manufacturer in China to pass the GMP pilot inspection and audit by the National Medical Products Administration.
Lepu (Beijing) Medical Equipment Co., Ltd. is located in Changping Science Park, Zhongguancun Science Park. He was recognized as "Beijing High-tech Enterprise", "One Hundred Innovative Pilot Enterprises in Zhongguancun Science Park" and "Beijing Enterprise Technology Center", and was awarded as "the most growing enterprise in the new material industry in 2006", becoming the executive director of the Surgical Implant Professional Committee of China Medical Device Industry Association. In June 2009, the company was awarded the title of "Best Growth Enterprise in New Materials Industry". In March 2009, the company was awarded the title of "Outstanding Contribution Enterprise Unit of Zhongguancun 20th Anniversary"; In June 2009, the company won the "Beijing Famous Trademark". Based on the enterprise spirit of "honesty, high quality, science and innovation", Lepu (Beijing) Medical Devices Co., Ltd. will wholeheartedly provide the best products and services for the majority of medical staff and patients, and strive to build a first-class national brand of interventional medical devices in China. On September 8th, 2006, 18 donated100000 yuan to China Biomedical Engineering Society.
On July 5, 2007, 522 coronary stents with a value of 6 million yuan were donated to the China Foundation for the Development of Aging, which was used for the large-scale public welfare activities of the China Foundation for the Development of Aging.
In May 2008, all colleagues of Lepu Medical spontaneously organized a donation activity of "Unity is strength, earthquake relief" to help the people affected by the Wenchuan earthquake in Sichuan, and donated 32,835 yuan that day, which was quickly donated to the disaster area through the Changping Red Cross Society in Beijing.
In May, 2008, Lepu Medical donated 300,000 yuan to the "Wenchuan Rescue Action" initiated by the Beijing Red Cross Society, and timely allocated 65,438+000 sets of central venous catheter products for disaster relief intensive care in Sichuan earthquake-stricken areas.
In June 2008, the company donated 200,000 yuan in cash to Pengzhou Health Center through Chengdu Health Bureau for disaster relief in Sichuan earthquake-stricken areas.
In April, 2009, the company started the donation of heart occluders to help children from poor families all over the country. Lepu Children's Aid Society donated 6,543,800 yuan for the project operation, and the Children's Aid Society will certainly make good use of this money to make greater contributions to more children in need. Executive Vice President Yang Jianchang, Vice President Zhao and Secretary General, and Vice President Liu Liangyu presented honorary certificates to General Manager Pu Zhongjie on behalf of China Social Workers Association, thanking Lepu (Beijing) Medical Devices Co., Ltd. for its contribution to the field of congenital heart disease in children.
On the morning of March 3rd, 2065438, the donation ceremony between Lepu Company and the Children's Rescue Committee of China Social Workers Association was held in the conference room on the third floor of China Social Workers Association. Yang Jianchang, executive vice president, Zhao, vice president and secretary general, Liu Liangyu, vice president, Zhang Wen, director and deputy director of the Children's Rescue Committee of China Social Workers Association, Wang Lingyan, director and deputy director of the "Love Hope" medical project office, Pu Zhongjie, general manager of Lepu (Beijing) Medical Devices Co., Ltd., and general manager of Shanghai Shape Memory Alloy attended the donation ceremony.
On 20 10, 2 1, Lepeng made the first donation of 65,438+10,000 yuan to Yushu victims.